Scarica l'app Stockscreener
223.70
1.52%
3.4307
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$220.27
Aprire:
$220.96
Volume 24 ore:
353.30K
Relative Volume:
0.18
Capitalizzazione di mercato:
$52.64B
Reddito:
$244.67B
Utile/perdita netta:
$1.68B
Rapporto P/E:
32.19
EPS:
6.9487
Flusso di cassa netto:
$5.51B
1 W Prestazione:
+8.11%
1M Prestazione:
+11.19%
6M Prestazione:
+41.84%
1 anno Prestazione:
+74.17%
Intervallo 1D:
$219.72
$223.72
Intervallo di 1 settimana:
$212.03
$230.81
Portata 52W:
$120.72
$230.81
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
223.72 | 51.83B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
940.09 | 114.55B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
361.84 | 70.03B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
81.27 | 9.54B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.41 | 793.60M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health (NYSE:CAH) Given New $248.00 Price Target at Argus - MarketBeat
Wells Fargo Raises Price Target for Cardinal Health (CAH) | CAH Stock News - GuruFocus
Nasogastric Tubes Market Is Booming Worldwide 2026-2033 | - openPR.com
Wells Fargo Adjusts Price Target on Cardinal Health to $256 From $237, Maintains Overweight Rating - marketscreener.com
Candriam S.C.A. Acquires 19,155 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Fresh Look At Cardinal Health (CAH) Valuation After Mixed Recent Share Performance - Sahm
Earnings Winners: 2 Buy Rated Stocks Raising Guidance - Finviz
Lasix ONYU Gains Major Distributor Access Through Cardinal Health and Cencora - Pharmaceutical Commerce
Morgan Stanley raises Cardinal Health, Inc. (CAH) price target after strong Q2 - MSN
Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2 - Finviz
Cardinal Health CEO Jason Hollar says Central Ohio is key to achieving record revenueColumbus Business First - The Business Journals
Cardinal Health, Inc. (CAH) shares gain favor as Citi turns bullish on specialist assets - MSN
Why Cardinal Health (CAH) Is Up 5.3% After Raising Full-Year Earnings Guidance Again And Boosting Buybacks - Yahoo Finance
Cardinal Health price target raised to $255 from $245 at Morgan Stanley - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Cardinal Health (CAH) - The Globe and Mail
Cardinal Health (NYSE:CAH) Price Target Raised to $260.00 - MarketBeat
Cardinal Health, Inc. $CAH Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade) - Seeking Alpha
Cardinal Health Guidance Hike Sparks Questions On Valuation And Growth Drivers - Sahm
UBS Adjusts Cardinal Health Price Target to $260 From $250, Maintains Buy Rating - marketscreener.com
Cardinal Health (CAH) Receives Rating Update and Price Target In - GuruFocus
Cardinal Health stock hits all-time high at $229.87 By Investing.com - Investing.com Canada
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock - Yahoo Finance
Evercore ISI Adjusts Cardinal Health Price Target to $260 From $250 - marketscreener.com
Mizuho Adjusts Price Target on Cardinal Health to $235 From $222, Maintains Outperform Rating - marketscreener.com
Cardinal Health, Inc. (NYSE:CAH) Q2 2026 Earnings Call Transcript - Insider Monkey
CAH Q4 Deep Dive: Specialty and Growth Segments Drive Outperformance and Upgraded Outlook - Finviz
Cardinal Health Q2 Earnings Call Highlights - MarketBeat
Is Cardinal Health (CAH) Pricing Reflect Its Surge And Role In The Healthcare Supply Chain - Yahoo Finance
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health (NYSE:CAH) Exceeds Q4 CY2025 Expectations - The Globe and Mail
Cardinal Health boosts annual profit forecast on surging demand for specialty drugs - 104.1 WIKY
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health boosts annual profit forecast banking on surging demand for specialty drugs - MSN
Cardinal Health Inc (CAH) Q2 2026 Earnings Call Highlights: Robu - GuruFocus
Cardinal Health Inc (CAH) Q2 2026 Earnings Call Highlights: Robust Revenue Growth and Raised ... By GuruFocus - Investing.com Canada
Why Is Cardinal Health (CAH) Stock Rocketing Higher Today - Finviz
Cardinal Health Shares Jump After Lifting Outlook on Pharma Momentum - The Wall Street Journal
Evercore ISI Raises Cardinal Health Price Target to $260 From $250 - marketscreener.com
Cardinal's Growth Engine Fires Across the Portfolio From Utilization Strength and New Acquisitions - morningstar.com
The $65.6 Billion Secret Wall Street Doesn’t Want You to Know About Cardinal Health - Yahoo Finance
Cardinal Health (CAH) Stock: Hits Fresh Momentum After Strong Q2 and $750M Buyback Boost - CoinCentral
Cardinal Health (NYSE:CAH) Releases Earnings Results - MarketBeat
Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. - Barron's
Cardinal Health Inc (CAH) Trading Down 0% on Feb 5 - GuruFocus
Cardinal Health Surges on Strong Q2 Results and Upgraded FY26 Ou - GuruFocus
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday - Benzinga
Cardinal Health CFO talks healthcare demand from aging population - Yahoo Finance
Cardinal Health (CAH) Sees Significant Stock Increase - GuruFocus
Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That. - Barron's
CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains - TradingView
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):